Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Ann Acad Med Singap. 2008 Dec;37(12 Suppl):97-4.
Newborn screening (NBS) in the United States (US) has existed since the early 1960s and is required in all 51 state jurisdictions. It is generally recognised that NBS provides a significant public health benefit by preventing or markedly decreasing the adverse medical consequences of conditions included in the screening panel. There is currently no US national NBS policy, so instead there are 51 independent state programmes that vary widely in their policies, infrastructures, procedures and services. Not surprisingly, US NBS programme costs and methods of financing also vary. Surveys have increasingly found a reliance on fees to pay for screening tests, short-term follow-up and other parts of state NBS systems. This article reviews some of the current US NBS financing issues and methodologies.
美国的新生儿筛查（NBS）自 20 世纪 60 年代初就已存在，并且在美国 51 个州的司法管辖区都有要求。人们普遍认为，NBS 通过预防或显著减少筛查组中包含的病症的不良医疗后果，提供了重大的公共卫生效益。目前，美国没有国家 NBS 政策，因此，51 个独立的州计划存在广泛的政策、基础设施、程序和服务差异。毫不奇怪，美国 NBS 计划的成本和融资方式也有所不同。调查越来越多地发现，筛查测试、短期随访和州 NBS 系统的其他部分依赖于收费来支付。本文回顾了一些当前美国 NBS 融资问题和方法。
